Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2006
06/22/2006US20060136136 Crystal structure of baff, and use thereof in drug design
06/22/2006US20060135861 Apparatus and method for blood analysis
06/22/2006US20060135750 Novel protein and gene encoding the same
06/22/2006US20060135560 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
06/22/2006US20060135509 10-(3-(N,N-dimethylamino)propyl)phenothiazine; replaces or enhances the function of SMN to alleviate or reduce a phenotype of a cell with low SMNprotein levels; gene therapy; neurogenative diseases; psychological disorders;spinal muscular atrophy
06/22/2006US20060135490 Targeting mPGES-1 as a treatment for inflammation which avoids cardiovascular risk
06/22/2006US20060135456 Methods and compositions for RNA interference
06/22/2006US20060135445 Breast cancer-resistant protein inhibitor
06/22/2006US20060135420 Method of diagnosing non-alcoholic steatohepatitis (nash) using molecular markers
06/22/2006US20060135419 Proteins involved in the regulation of energy homeostasis
06/22/2006US20060135417 Use of the crh (corticotropin releasing hormone)-ucn (urocortin) system in the treatment of inflammatory diseases
06/22/2006US20060135415 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
06/22/2006US20060135412 Methods for the treatment of alzheimers disease and compositions therefore
06/22/2006US20060135410 Targeted delivery to legumain-expressing cells
06/22/2006US20060135401 Novel method of selecting immunosuppressant having little thrombocytopenic effect
06/22/2006US20060135055 Quality control device for solid, pharmaceutical products
06/22/2006US20060134806 Method of separating unattached Raman-active tag from bioassay or other reaction mixture
06/22/2006US20060134805 Purification of immunoglobulins
06/22/2006US20060134804 use the interaction of colored signals from the positive control area and the analyte binding area to form a recognizable symbol that provides the test result
06/22/2006US20060134803 chromatographic quick test strips for detection of a ligand in a body fluid; does not require migration of analytes
06/22/2006US20060134802 Solid-phase immunochromatographic methods
06/22/2006US20060134799 Fluid on surface of support increases viscosity when heated, having first micro-components suspended therein each adapted to engage binding sites; for flat panel displays
06/22/2006US20060134797 biosensors comprising surfaces immobilized with energy absorbing molecules and affinity reagents, used to analyze macromolecules, such as proteins; matrix-assisted laser desorption/ionization, time-of-flight mass spectrometry
06/22/2006US20060134795 Buffering the peroxyacetic acid-containing water and the use of a N,N-diethyl-p-phenylenediamine (DPD) indicator system in the presence of iodide ion
06/22/2006US20060134794 Method of detecting the presence and/or progression of cancer
06/22/2006US20060134775 Systems, illumination subsystems, and methods for increasing fluorescence emitted by a fluorophore
06/22/2006US20060134774 Detection of protease enzymes
06/22/2006US20060134773 Device for pretreating specimen
06/22/2006US20060134767 Mitotic kinesin binding site
06/22/2006US20060134741 Composition and methods relating to SENP1-a sentrin-specific protease
06/22/2006US20060134740 Engineered proteases for affinity purification and processing of fusion proteins
06/22/2006US20060134732 Methods and compositions for a microemulsion-based tissue treatment
06/22/2006US20060134723 N-or C-terminal peptide selection method for proteomics
06/22/2006US20060134722 Method and compositions for detecting botulinum neurotoxin
06/22/2006US20060134720 Method for analyzing c-terminal amino acid sequence of peptide using mass spectrometry
06/22/2006US20060134719 Novel serine protease
06/22/2006US20060134718 Assay for camp based on exclusive binding of camp to the b-binding sites of camp dependent protein kinase (capk)
06/22/2006US20060134717 Method for making biochips
06/22/2006US20060134713 Biosensor apparatus and methods of use
06/22/2006US20060134712 measuring a plurality of analytes that may be present in very different abundances, where analytes have different affinities to binding reagents used in the assays and/or assays for each of the analytes have different sensitivities
06/22/2006US20060134711 For determination of drugs of abuse in biological samples, in particular, to immunoassay, for determination of amphetamine-class drugs, and more particularly, to methamphetamine derivatives
06/22/2006US20060134710 WDR11 protein assay
06/22/2006US20060134709 Molecules having a variant Fc region, wherein region comprises at least one amino acid modification relative to a wild-type Fc region; modified molecules confer an effector function to a molecule, where the parent molecule does not detectably exhibit this effector function; utility in cancer treatment
06/22/2006US20060134708 Detection and treatment of renal cancer
06/22/2006US20060134707 Hybridoma cell lines; rapid test kits
06/22/2006US20060134706 Atopic dermatitis inducer
06/22/2006US20060134705 Cvd assay
06/22/2006US20060134704 Microwell array chip for detecting antigen-specific lymphocytes, method of detecting and method of manufacturing antigen-specific lymphocytes, and method of cloning antigen-specific lymphocyte antigen receptor genes
06/22/2006US20060134700 Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance
06/22/2006US20060134699 Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance
06/22/2006US20060134698 Methods for treating cardiac disease by modifying an N-terminal domain of troponin I
06/22/2006US20060134695 Biosensor surface structures and methods
06/22/2006US20060134694 Methods of protein profiling by thiolation
06/22/2006US20060134693 Olfactory cyclic nucleotide-gated channel cell-based assays to identify T1R and T2R taste modulators
06/22/2006US20060134692 Target activated microtransfer
06/22/2006US20060134691 Labeling methodology comprising oligopeptides
06/22/2006US20060134690 Process for the purification of interleukin-4 and its muteins
06/22/2006US20060134688 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets
06/22/2006US20060134685 Use of a biochip for the diagnosis of sepsis or sepsis related syndrome
06/22/2006US20060134681 Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay
06/22/2006US20060134678 Methods for drug discovery disease treatment, and diagnosis using metabolomics
06/22/2006US20060134677 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
06/22/2006US20060134676 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
06/22/2006US20060134672 Macromolecular arrays on polymeric brushes & methods for preparing the same
06/22/2006US20060134670 Enabling tools to identify ligands for hormone nuclear receptors
06/22/2006US20060134669 Plasmon resonance biosensor and method
06/22/2006US20060134668 Methods for treating patients and identifying therapeutics
06/22/2006US20060134666 Methods for detecting nucleic acid analyte
06/22/2006US20060134656 Reduction of non-specific adsorption of biological agents on surfaces
06/22/2006US20060134655 Introducing a polynucleotide expressing a cGMP-visualizing probe into cells, whereby the cGMP-visualizing probe is expressed and made to coexist with cGMP; measuring the change in fluorescence wavelength
06/22/2006US20060134654 ADAM12, a novel marker for abnormal cell function
06/22/2006US20060134647 Method for elimination of false reactivities in immunoassay for Hepatitis A virus
06/22/2006US20060134646 Method for treatment of HIV infection
06/22/2006US20060134644 Apparatus and methods for detecting target analyte
06/22/2006US20060134641 Utilizing multifunctional enzyme having chymotrypsin, trypsin, elastase, collagenase and/or exopeptidase activity
06/22/2006US20060134639 Method for the determination of cellular transcriptional regulation
06/22/2006US20060134636 Standardization of growth conditions for human embryonic stem cells intended for use in regenerative medicine
06/22/2006US20060134629 Methods and compositions for elucidating protein expression profiles in cells
06/22/2006US20060134623 Novel compositions and methods in cancer
06/22/2006US20060134622 Amplified cancer target genes useful in diagnosis and thereapeutic screening
06/22/2006US20060134610 Chris-like virus, compositions, vaccines and uses thereof
06/22/2006US20060134608 Chemically amplified electrochemical detection of affinity reaction
06/22/2006US20060134606 Bio-material immobilized on corona-treated surface of nitrocellulose coating; associated with fluorophore or luminescent tag; use for biopsies or contaminated water
06/22/2006US20060134605 Platelet biomarkers for the detection of disease
06/22/2006US20060134604 Flexible method and apparatus for high throughput production and purification of multiple proteins
06/22/2006US20060134602 Methods of identifying cytotoxic effects in quiescent cells
06/22/2006US20060134599 Microfluidic device for cell separation and uses thereof
06/22/2006US20060134595 Polymer affinity matrix, a method for the production and use thereof
06/22/2006US20060134198 Pharmaceutical compositions with improved dissolution
06/22/2006US20060134126 Peptide constructs for treating disease
06/22/2006US20060134125 Purification of antigen-specific T cells
06/22/2006US20060134121 DII4 antagonists, assays, and therapeutic methods thereof
06/22/2006US20060134120 Multiple marker assay for detection of ovarian cancer
06/22/2006US20060134117 Preventives/remedies for cancer
06/22/2006US20060134115 Method of screening for sensitivity to kinase inhibitor therapy
06/22/2006US20060134108 Method for retarding or precluding Alzheimer's dementia
06/22/2006US20060134100 Dc-sign blockers and their use for preventing or treating viral infections
06/22/2006US20060134063 Agents for proliferating pancreatic beta-cells of the islets of langerhans, agents for suppressing apoptosis of said cells, and screening of candidate compounds for these agents
06/22/2006US20060134005 In-vivo monitoring of circulating apoptotic cells
06/22/2006US20060134002 Labelling with fluorescent probes, illuminating, and detecting